Ślusarczyk, A.; Wolański, R.; Miłow, J.; Piekarczyk, H.; Lipiński, P.; Zapała, P.; Niemczyk, G.; Kurzyna, P.; Wróbel, A.; Różański, W.;
et al. Can We Go beyond Pathology? The Prognostic Role of Risk Scoring Tools for Cancer-Specific Survival of Patients with Bladder Cancer Undergoing Radical Cystectomy. Biomedicines 2024, 12, 1541.
https://doi.org/10.3390/biomedicines12071541
AMA Style
Ślusarczyk A, Wolański R, Miłow J, Piekarczyk H, Lipiński P, Zapała P, Niemczyk G, Kurzyna P, Wróbel A, Różański W,
et al. Can We Go beyond Pathology? The Prognostic Role of Risk Scoring Tools for Cancer-Specific Survival of Patients with Bladder Cancer Undergoing Radical Cystectomy. Biomedicines. 2024; 12(7):1541.
https://doi.org/10.3390/biomedicines12071541
Chicago/Turabian Style
Ślusarczyk, Aleksander, Rafał Wolański, Jerzy Miłow, Hanna Piekarczyk, Piotr Lipiński, Piotr Zapała, Grzegorz Niemczyk, Paweł Kurzyna, Andrzej Wróbel, Waldemar Różański,
and et al. 2024. "Can We Go beyond Pathology? The Prognostic Role of Risk Scoring Tools for Cancer-Specific Survival of Patients with Bladder Cancer Undergoing Radical Cystectomy" Biomedicines 12, no. 7: 1541.
https://doi.org/10.3390/biomedicines12071541
APA Style
Ślusarczyk, A., Wolański, R., Miłow, J., Piekarczyk, H., Lipiński, P., Zapała, P., Niemczyk, G., Kurzyna, P., Wróbel, A., Różański, W., Radziszewski, P., & Zapała, Ł.
(2024). Can We Go beyond Pathology? The Prognostic Role of Risk Scoring Tools for Cancer-Specific Survival of Patients with Bladder Cancer Undergoing Radical Cystectomy. Biomedicines, 12(7), 1541.
https://doi.org/10.3390/biomedicines12071541
